Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 13, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem Announces Licensing Agreement and Plans to Begin Phase 2 Hepatocellular Carcinoma Trial in China

NEW YORK, May 13, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, announced today that the Company has signed an...
May 08, 2014 16:10 ET | Source: Lisata Therapeutics

NeoStem Announces Closing of Acquisition of California Stem Cell, Inc. and First Quarter 2014 Financial Results

NEW YORK, May 8, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, today announced first quarter 2014 financial...
May 05, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem and Progenitor Cell Therapy (PCT) to Present at Multiple May Conferences

NEW YORK, May 5, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, announced today that the Company and its...
April 30, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem's Subsidiary, Progenitor Cell Therapy Enters Into a Services Agreement With IRX Therapeutics, Inc.

NEW YORK, April 30, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) and its subsidiary, Progenitor Cell Therapy, LLC ("PCT"), announced the execution of a Services Agreement with IRX Therapeutics,...
April 14, 2014 07:00 ET | Source: Lisata Therapeutics

NeoStem Announces Definitive Agreement to Acquire California Stem Cell, Inc.

NEW YORK, April 14, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, announced today that it has entered into a...
April 11, 2014 16:13 ET | Source: Lisata Therapeutics

NeoStem Announces Conference Call and Webcast

NEW YORK, April 11, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, announced today that it plans to conduct a...
April 03, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem Welcomes Dr. Adel Nada as Vice President, Immunotherapy

NEW YORK, April 3, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, announced today the appointment of Dr. Adel...
April 01, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem and Progenitor Cell Therapy (PCT) to Present at Multiple April Conferences

NEW YORK, April 1, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, announced today that the Company and its...
March 31, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem Congratulates Lee Clough on Winning Award From American Society for Apheresis

NEW YORK, March 31, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, announced today that Lee Clough, RN, HP...
March 26, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem Begins Research Collaboration for Treatment of Skin Wounds in Scleroderma

NEW YORK, March 26, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, today announced that it has signed an...